點擊圖片查看原圖
中文名稱：西格列汀雜質(zhì)，替米沙坦雜質(zhì)對照品
英文名稱：Sitagliptin Impurity，Telmisartan Impurity
規(guī)格：10mg/25mg/50mg/100mg等多種規(guī)格可選。
用途：實驗研發(fā)，藥品申報檢測，不得用于臨床醫(yī)學(xué)診斷。
隨貨提供：所有雜質(zhì)對照品均隨貨提供HPLC，NMR，MS圖譜及CoA證書。
保存及取用：為了防止產(chǎn)品含量降低，應(yīng)防潮，避光和抗氧化包裝，保存應(yīng)以提高物質(zhì)穩(wěn)定性為原則。如果一次使用很少量，可以將其適當(dāng)分裝后使用，這樣可以有效的防止試劑污染。請不要在臟亂和強光環(huán)境中取用，以免造成污染和失效。
西格列汀雜質(zhì)，替米沙坦雜質(zhì)對照品 雜質(zhì)列表：
| Sitagliptin | (R)-3-amino-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)butan-1-one | |
| Sitagliptin Impurity 1 | (R)-3-((tert-butoxycarbonyl)amino)-4-(3,4-difluorophenyl)butanoic acid | |
| Sitagliptin Impurity 2 | (R)-3-((tert-butoxycarbonyl)amino)-4-(2,4-difluorophenyl)butanoic acid | |
| Sitagliptin Impurity 3 | (R)-3-((tert-butoxycarbonyl)amino)-4-(2,5-difluorophenyl)butanoic acid | |
| Sitagliptin Impurity 4 | (S)-3-((tert-butoxycarbonyl)amino)-4-(2,4,5-trifluorophenyl)butanoic acid | (S)-Sitagliptin N-Boc-Acid Impurity |
| Sitagliptin Impurity 5 | (R)-methyl 3-((tert-butoxycarbonyl)amino)-4-(2,4,5-trifluorophenyl)butanoate | (R)-Sitagliptin N-Boc-Methyl-Ester Impurity |
| Sitagliptin Impurity 6 | (R)-methyl 3-amino-4-(2,4,5-trifluorophenyl)butanoate | (R)-Sitagliptin Methyl-Ester Impurity |
| Sitagliptin Impurity 7 | (R)-3-amino-4-(3,4-difluorophenyl)-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)butan-1-one | 2-Desfluoro Sitagliptin |
| Sitagliptin Impurity 8 | (R)-3-amino-4-(2,4-difluorophenyl)-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)butan-1-one | 5-Desfluoro Sitagliptin |
| Sitagliptin Impurity 9 | (R)-3-amino-4-(2,5-difluorophenyl)-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)butan-1-one | 4-Desfluoro Sitagliptin |
| Sitagliptin Impurity 10 | (R)-3-((tert-butoxycarbonyl)amino)-4-(2,4,5-trifluorophenyl)butanoic acid | (R)-Sitagliptin N-Boc-Acid Impurity |
| Sitagliptin Impurity 11 | (R)-tert-butyl (4-oxo-4-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-yl)carbamate | Sitagliptin N-Boc Impurity |
| Sitagliptin Impurity 12 | (S)-3-amino-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)butan-1-one | Sitagliptin (S)-Isomer |
| Sitagliptin Impurity 13 | 1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)butane-1,3-dione | Sitagliptin Ketoamide Impurity |
| Sitagliptin Impurity 14 | (Z)-3-amino-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)but-2-en-1-one | Sitagliptin Enamine Impurity |
| Sitagliptin Impurity 15 | (R)-3-amino-4-(2,4,5-trifluorophenyl)butanoic acid | Sitagliptin Acid Impurity |
| Sitagliptin Impurity 16 | (E)-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)but-2-en-1-one | 3-Desamino-2,3-dehydro Sitagliptin |
| Sitagliptin Impurity 17 | (E)-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)but-3-en-1-one | 3-Desamino-3,4-dehydro Sitagliptin |
| Telmisartan | 4'-((1,7'-dimethyl-2'-propyl-1H,3'H-[2,5'-bibenzo[d]imidazol]-3'-yl)methyl)-[1,1'-biphenyl]-2-carboxylic acid | |
| Telmisartan Impurity 1 | 1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzo[d]imidazole | |
| Telmisartan Impurity 2 | 4'-((1,7'-dimethyl-2'-propyl-1H,1'H-[2,5'-bibenzo[d]imidazol]-1'-yl)methyl)-[1,1'-biphenyl]-2-carboxylic acid | |
| Telmisartan Impurity 3 | tert-butyl 4'-((1,7'-dimethyl-2'-propyl-1H,3'H-[2,5'-bibenzo[d]imidazol]-3'-yl)methyl)-[1,1'-biphenyl]-2-carboxylate | |
| Telmisartan Impurity 4 | 1-((2'-carboxy-[1,1'-biphenyl]-4-yl)methyl)-4-methyl-2-propyl-1H-benzo[d]imidazole-6-carboxylic acid | |
| Telmisartan Impurity 5 | 4'-((1,7'-dimethyl-2'-propyl-1H,3'H-[2,5'-bibenzo[d]imidazol]-3'-yl)methyl)-[1,1'-biphenyl]-2-carboxamide | |
| Telmisartan Impurity 6 | 4'-((1,7'-dimethyl-2'-propyl-1H,3'H-[2,5'-bibenzo[d]imidazol]-3'-yl)methyl)-[1,1'-biphenyl]-2-carbonitrile | |
| Telmisartan Impurity 7 | tert-butyl 4'-(bromomethyl)-[1,1'-biphenyl]-2-carboxylate |
西格列汀雜質(zhì)，替米沙坦雜質(zhì)對照品 訂購方式：
聯(lián)系人：何先生
手機：15012456311
QQ：781007885
郵箱：phastandards@gmail.com
歡迎您通過電話，電郵或在線客服向我司詢價及訂購產(chǎn)品。
西格列汀雜質(zhì)，替米沙坦雜質(zhì)對照品 深圳遠揚專注醫(yī)藥標(biāo)準(zhǔn)品，雜質(zhì)對照品，更多產(chǎn)品，歡迎選購（篇幅有限，只列舉了一小部分，更多更全，請來電詳詢）：
NIBSC標(biāo)準(zhǔn)品部分產(chǎn)品列表：
07/346 BCG Vaccine of Russian BCG-I sub-strain(73st WHO Reference Reagent)
10/150 Reteplase Reference Material
13/215 C-Peptide, Human. 70st International Standard.
13/163 C-Peptide, Human. 18st International Standard.
07/313 BCG Vaccine of Russian BCG-I sub-strain(40st WHO Reference Reagent)
13/253 Polio Anti Sabin type 36 (inactivated) Serum
12/B623-048 QCRFLUAH1N1QC1-Influenza AH1N1 QC46
01/430 Meningococcal serogroup W polysaccharide
13/175 C-Peptide, Human. 30st International Standard.
13/304 Polio Anti Sabin type 87 (inactivated) Serum
95/621 Interleukin-82 (Human, rDNA derived)
10/112 Reteplase Reference Material
13/284 Polio Anti Sabin type 67 (inactivated) Serum
95/650 Interleukin-111 (Human, rDNA derived)
13/218 Polio Anti Sabin type 1 (inactivated) Serum
01/514 Meningococcal serogroup W polysaccharide
01/457 Meningococcal serogroup W polysaccharide
13/282 Polio Anti Sabin type 65 (inactivated) Serum
95/591 Interleukin-52 (Human, rDNA derived)
12/B623-027 QCRFLUAH1N1QC1-Influenza AH1N1 QC25
03/104-070 HTLV-55 (antibody) Monitor Sample
12/B623-031 QCRFLUAH1N1QC1-Influenza AH1N1 QC29
01/458 Meningococcal serogroup W polysaccharide
13/195 C-Peptide, Human. 50st International Standard.
95/608 Interleukin-69 (Human, rDNA derived)
01/436 Meningococcal serogroup W polysaccharide
10/182 Reteplase Reference Material
13/192 Influenza Antigen B/Massachusetts/02/2070 (Egg derived)
10/159 Reteplase Reference Material
07/307 BCG Vaccine of Russian BCG-I sub-strain(34st WHO Reference Reagent)
03/104-088 HTLV-73 (antibody) Monitor Sample
13/213 Influenza Antigen B/Massachusetts/02/2091 (Egg derived)
13/216 Influenza Antigen B/Massachusetts/02/2094 (Egg derived)
95/647 Interleukin-108 (Human, rDNA derived)
03/104-043 HTLV-28 (antibody) Monitor Sample
12/B623-069 QCRFLUAH1N1QC1-Influenza AH1N1 QC67
13/287 Polio Anti Sabin type 70 (inactivated) Serum
95/632 Interleukin-93 (Human, rDNA derived)
13/168 C-Peptide, Human. 23st International Standard.
13/236 C-Peptide, Human. 91st International Standard.
13/279 Polio Anti Sabin type 62 (inactivated) Serum
西格列汀雜質(zhì)，替米沙坦雜質(zhì)對照品雜質(zhì)對照品部分產(chǎn)品列表：氯苯達諾雜質(zhì)，阿伐那非雜質(zhì)，泛昔洛韋雜質(zhì)，恩替卡韋雜質(zhì)，阿齊沙坦雜質(zhì)，泰妙菌素雜質(zhì)，齊拉西酮雜質(zhì)，依度沙班雜質(zhì)，鹽酸阿扎司瓊雜質(zhì)，鹽酸羅匹尼羅雜質(zhì)，Lesinurad雜質(zhì)，替吉奧雜質(zhì)，左氧氟沙星雜質(zhì)，戊乙奎醚雜質(zhì)，雷貝拉唑鈉雜質(zhì)，西格列汀雜質(zhì)，氯替潑諾雜質(zhì)，達馬莫德雜質(zhì)，本芴醇雜質(zhì)，磷酸奧司他韋雜質(zhì)，羅氟司特雜質(zhì)，莫西沙星雜質(zhì)，阿法替尼雜質(zhì)，鹽酸度洛西汀雜質(zhì)，麥考酚酯雜質(zhì)，雷洛昔芬雜質(zhì)，氯吡格雷雜質(zhì)，他米巴羅汀雜質(zhì)，奧曲肽雜質(zhì)，氨甲環(huán)酸雜質(zhì)，沙芬酰胺雜質(zhì)，托拉菌素雜質(zhì)，阿托品雜質(zhì)，西格列汀雜質(zhì)，鹽酸雷莫司瓊雜質(zhì)，塞來昔布雜質(zhì)，卡利拉嗪雜質(zhì)，來那度胺雜質(zhì)，硝唑尼特雜質(zhì)，埃博霉素雜質(zhì)，甲磺酸伊馬替尼雜質(zhì)，依帕司他雜質(zhì)，阿托伐他汀雜質(zhì)，依折麥布雜質(zhì)，吲達帕胺雜質(zhì)，吉非替尼雜質(zhì)